In the first Peter Mac Spotlight Series you’ll hear from
@PrDavidBowtell @DaleGarsed @kylie_gorringe@elaine_sanij & @g_auyeung and their groundbreaking work that's leading to new hope for women with #ovariancancer across the globe. Click and listen now. https://t.co/gb1w0Y0SFf
Hot off the press: 📣 the latest from our work unravelling the secrets behind exceptional responses to treatment for #ovariancancer led by @DrDaleGarsed. With thanks to all our collaborators and patients from 🇦🇺 & 🌎
In a large international study of more than 7000 patients with #OvarianCancer, we found that combined loss of RB1 protein & BRCA gene mutation predicts 🔼 immunologic responses and long-term survival in the high-grade serous subtype. Online NOW @CCR_AACR https://t.co/Ujnm5Lz8bA
Read the latest research from the Christie lab @PeterMacRes on MHCII and whole genome duplication in ovarian cancer, published with @SpringerNature in @NatureComms https://t.co/0nZEMq1ObW
Congratulations to @g_auyeung and Dr Sathya Manoharan and team from @PeterMacCC @BowtellLab on completing and presenting this investigator- initiated BEACON trial showing interesting activity of a non- chemo combo in platinum resistant ovarian cancer
Incredibly excited and grateful to receive an @nhmrc Ideas Grant to explore immune responses in patients with #OvarianCancer who are exceptionally long-term survivors, in collaboration with @BowtellLab@PeterMacCC & the Nelson Lab @BCCancer https://t.co/CmDzmYP5wZ
Researchers from @BowtellLab, AOCS and Christie Labs met today with a team of passionate #ovariancancerconsumers & advocates we’ve engaged with for a number of years now. A lovely catch up, research update & discussion about the important role consumers play in #advancingresearch
Congratulations to @g_auyeung for winning one of the @PeterMacCC awards this afternoon for World’s best cancer discovery and translation. For finding better options for CCNE over-expressed or amplified ovarian cancer! @BowtellLab
Next in the spotlight at #IGCS2023 Dr Nikki Burdett’s work from her thesis in @DrLizChristie lab illustrating the tumour heterogeneity in HGSOC from primary to end stage disease @PMPostdocs@PeterMacRes 🔥
Thanks to the #IGCS2023 scientific committee for selecting our IGNITE abstract as best oral abstract! Proud to be representing @anzgog@PeterMacCC and thx to the whole study team especially @LindaMileshkin@BowtellLab for giving me the opportunity to lead the study
So pleased and proud to see @g_auyeung win the award for best oral abstract at #IGCS2023 this morning in Seoul. A tribute to all his hard work towards improving outcomes for women with CCNE1 driven ovarian cancer who don’t do so well with SOC @BowtellLab@PeterMacRes@anzgog
Prof David Bowtell @bowtelllab was honoured to give the AACR Foundation Special Conference on Ovarian Cancer opening keynote address. He shared where his lab has directed their efforts to maximise returns in #OvarianCancer#research#cancer#GynecologicalCancer
Congratulations to @BowtellLab’s Dr Rachel Delahunty! Rachel’s PhD described the TRACEBACK genetic testing program, which aims to utilise genetic testing to help reduce the number of #ovariancancer and other hereditary cancer diagnoses in Australia 🧬
2023 Picchi Award winners:
🏆Clinical Science - Dr Aaron Wong, @StVincentsMel, @TheRMH, @PeterMacCC
🏆 Basic Science - Amanda Chen, @PeterMacCC
🏆 Population Health - Rachel Delahunty, @PeterMacCC
Exceptional work by these early career researchers!
https://t.co/a8v4tbqfX9
Collaboration is a necessity in ensuring a relevant, vibrant, impactful research agenda 🤝
One particular example of collaboration at ANZGOG is between scientists and clinicians, who work together to advance research 'bench to bedside' for gynaecological cancer patients.
Why do some people survive cancer?
David Bowtell, Co-head of the Women’s Cancer Program at the Peter MacCallum Cancer Centre, has been studying ovarian cancer patients who have beaten the odds.
#OvarianCancer#CancerSurvivors@PeterMacCC
https://t.co/Kin8z8R1gW
Three Peter Mac staff were recognised with prestigious awards at the @anzgog Annual Scientific Meeting overnight. Congratulations to Professor @LindaMileshkin, Professor David Bowtell (@BowtellLab) and Dr Nikki Burdett. Read more: https://t.co/T2xHcDXXi9
The incredible contributions of @PeterMacCC@PeterMacRes Prof David Bowtell @BowtellLab & Prof @LindaMileshkin for their outstanding contributions to gynae cancer research & practice recognised by @anzgog ! And up and coming ⭐️ Dr Nikki Burdett (Christie Lab)